| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 61,046 | 64,232 | 59,871 | 54,819 |
| Cost of sales | 15,091 | 19,258 | 18,451 | 17,641 |
| Gross profit | 45,955 | 44,974 | 41,420 | 37,178 |
| Sales and marketing | 11,923 | 14,895 | 14,212 | 11,441 |
| General and administrative | 10,750 | 10,396 | 10,487 | 8,933 |
| Research and development | 2,970 | 3,541 | 4,095 | 3,656 |
| Total operating expenses | 25,643 | 28,832 | 28,794 | 24,030 |
| Income from operations | 20,312 | 16,142 | 12,626 | 13,148 |
| Foreign currency loss | - | - | - | 202 |
| Interest income | 3,864 | 2,980 | 2,903 | 1,201 |
| Interest expense | 1,297 | 1,299 | 1,290 | - |
| Other income (loss), net | -306 | 247 | 2 | - |
| Income before income taxes | 22,573 | 18,070 | 14,241 | 14,551 |
| Provision for income taxes | 5,211 | 4,291 | 3,230 | 3,410 |
| Net income | 17,362 | 13,779 | 11,011 | 11,141 |
| Basic (in dollars per share) | 0.77 | 0.61 | 0.49 | 0.5 |
| Basic (in shares) | 22,660,000 | 22,614,000 | 22,570,000 | 22,476,000 |
| Diluted (in dollars per share) | 0.75 | 0.6 | 0.48 | 0.49 |
| Diluted (in shares) | 24,392,000 | 22,892,000 | 22,899,000 | 22,836,000 |
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)